Dlx-2, a transcriptional factor involved in embryonic development, tissue homeostasis, and the cell cycle [31, 32], is important in carcinogenesis; Dlx-2 expression correlates positively with more advanced cancer stages and with poor prognosis in a variety of human cancer types [33–36]. Here, DLX2 is linked to cancer.